Cambrex To Acquire Halo Pharma for $425 Million
By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization (CDMO),…
Sangamo Therapeutics To Acquire Biotech TxCell
By
Sangamo Therapeutics, a Richmond, California-based biopharmaceutical company, has agreed to acquire TxCell, a Valbonne, France-based biotechnology company developing personalized cellular immunotherapies, for approximately EUR 72 million ($84 million). TxCell is…
Novartis in $1.1-Billion mAb Mfg Pact with MorphoSys, Galapagos
By
Novartis has formed a deal with MorphoSys AG, a Planegg, Germany-based developer of antibodies, and Galapagos NV, a Mechelen, Belgium-based clinical-stage pharmaceutical company, to develop and commercialize their joint investigational,…
Moderna Opens Cell-Therapy Manufacturing Site
By
Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has opened a new manufacturing facility in Norwood, Massachusetts for clinical development of mRNA therapeutics. The 200,000-square-foot…